SCVP-ASIP Joint Symposium: Clonal Hematopoiesis: Impact on Inflammation and Cardiovascular Disease - Cardiac Pathology

SCVP-ASIP Joint Symposium: Clonal Hematopoiesis: Impact on Inflammation and Cardiovascular Disease - Cardiac Pathology

Friday, April 30, 2021 • 2:00 PM - 4:00 PM (EST)

Sponsored by the ASIP Inflammation/Immunopathology Scientific Interest Group and the Society for Cardiovascular Pathology (SCVP)

 

James Stone, MD, PhDChair
James Stone, MD, PhD
Massachusetts General Hospital

Session Description: The acquisition of aberrant clonal cell populations within the bone marrow has been observed during aging. It is now becoming clear that such clonal hematopoiesis may play important roles in age-related diseases, particularly inflammatory and age-related diseases of the cardiovascular system such as atherosclerosis. This session will involve leaders in the field sharing their insights into this new and evolving area of disease-related research.

  • Chair - Welcome and Introductions
  • 2:00 PM - 2:40 PM
    Clonal Hematopoiesis in Aging
    Rafael Bejar, MD, PhD • University of California, San Diego
  • 2:40 PM - 3:20 PM
    Clonal Hematopoiesis and Atherosclerotic Cardiovascular Disease
    Siddharth Jaiswal, MD, PhD • Stanford University
  • 3:20 PM - 4:00 PM
    Mechanistic Links Between Clonal Hematopoiesis and Age-Related Disease
    Kenneth Walsh, PhD • Hematovascular Biology Center
  • Questions and Answers